CN Patent

CN102232117A — 描绘肿瘤类型生物标志模式和特征集的基因靶和基因表达的蛋白靶

Assigned to Caris Life Sciences Inc · Expires 2011-11-02 · 15y expired

What this patent protects

本文提供了用于鉴定个体用的治疗剂的方法和系统，诸如之前未鉴定用于治疗个体的治疗剂。所述治疗剂可通过分子概况分析来鉴定，诸如确定个体生物样品的生物标志模式或特征集。

USPTO Abstract

本文提供了用于鉴定个体用的治疗剂的方法和系统，诸如之前未鉴定用于治疗个体的治疗剂。所述治疗剂可通过分子概况分析来鉴定，诸如确定个体生物样品的生物标志模式或特征集。

Drugs covered by this patent

Patent Metadata

Patent number
CN102232117A
Jurisdiction
CN
Classification
—
Expires
2011-11-02
Drug substance claim
No
Drug product claim
No
Assignee
Caris Life Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.